When Vedanta Executive Director Arun Misra addressed shareholders during the company’s March quarter earnings call last summer, his message was bold and optimistic. He said financial year 2024-25 ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, a clinical-stage company developing a potential new category of oral therapies based on defined bacterial consortia, today announced that the ...